Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lyon

Showing results (531-540 of 539) with videos related to

Pageof 54
Sort By:
You have reached the last page of results.This site can display upto 539 results.
Journal of the American College of Cardiology|February 8, 2020
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related MyocarditisMagid Awadalla, Syed S Mahmood, John D Groarke, et al.
European Journal of Heart Failure|April 17, 2019
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of CardiologyPetar M Seferović, Marija Polovina, Johann Bauersachs, et al.
European Heart Journal|March 1, 2020
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditisLili Zhang, Magid Awadalla, Syed S Mahmood, et al.
European Journal of Heart Failure|July 5, 2020
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)Jelena Čelutkienė, Radek Pudil, Teresa López-Fernández, et al.
Journal of the American College of Cardiology|March 26, 2021
Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated MyocarditisPaaladinesh Thavendiranathan, Lili Zhang, Amna Zafar, et al.
JACC. Cardiovascular Imaging|November 10, 2022
Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor MyocarditisThiago Quinaglia, Carlos Gongora, Magid Awadalla, et al.
European Journal of Heart Failure|August 1, 2024
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-OncologyCarlo Gabriele Tocchetti, Dimitrios Farmakis, Yvonne Koop, et al.
European Journal of Heart Failure|May 29, 2020
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology SocietyAlexander R Lyon, Susan Dent, Susannah Stanway, et al.
Circulation|April 17, 2019
Genetic Variants Associated With Cancer Therapy-Induced CardiomyopathyPablo Garcia-Pavia, Yuri Kim, Maria Alejandra Restrepo-Cordoba, et al.
Pageof 54

Showing results (531-540 of 539) with videos related to

Sort By:
Pageof 54
You have reached the last page of results.This site can display upto 539 results.
Journal of the American College of Cardiology|February 8, 2020
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related MyocarditisMagid Awadalla, Syed S Mahmood, John D Groarke, et al.
European Journal of Heart Failure|April 17, 2019
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of CardiologyPetar M Seferović, Marija Polovina, Johann Bauersachs, et al.
European Heart Journal|March 1, 2020
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditisLili Zhang, Magid Awadalla, Syed S Mahmood, et al.
European Journal of Heart Failure|July 5, 2020
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)Jelena Čelutkienė, Radek Pudil, Teresa López-Fernández, et al.
Journal of the American College of Cardiology|March 26, 2021
Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated MyocarditisPaaladinesh Thavendiranathan, Lili Zhang, Amna Zafar, et al.
JACC. Cardiovascular Imaging|November 10, 2022
Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor MyocarditisThiago Quinaglia, Carlos Gongora, Magid Awadalla, et al.
European Journal of Heart Failure|August 1, 2024
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-OncologyCarlo Gabriele Tocchetti, Dimitrios Farmakis, Yvonne Koop, et al.
European Journal of Heart Failure|May 29, 2020
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology SocietyAlexander R Lyon, Susan Dent, Susannah Stanway, et al.
Circulation|April 17, 2019
Genetic Variants Associated With Cancer Therapy-Induced CardiomyopathyPablo Garcia-Pavia, Yuri Kim, Maria Alejandra Restrepo-Cordoba, et al.
Pageof 54